This week, Dr. Brian Durie of the IMF answers a patient's question about the M protein and how levels are affected by time and treatment.

Previous Post
If bone density is low, does that mean myeloma is present?
Next Post
IMF’s Asian Myeloma Network Succeeds in Providing Access to Pomalidomide in Asia

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.